608 related articles for article (PubMed ID: 28123933)
1. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.
Zhao C; Liu L; Liu Q; Li F; Zhang L; Zhu F; Shao T; Barve S; Chen Y; Li X; McClain CJ; Feng W
Mol Metab; 2019 Nov; 29():145-157. PubMed ID: 31668386
[TBL] [Abstract][Full Text] [Related]
3. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
5. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
6. The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
Iizuka K
Nutrients; 2017 Feb; 9(2):. PubMed ID: 28241431
[TBL] [Abstract][Full Text] [Related]
7. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.
Zhang D; Tong X; VanDommelen K; Gupta N; Stamper K; Brady GF; Meng Z; Lin J; Rui L; Omary MB; Yin L
J Clin Invest; 2017 Jun; 127(7):2855-2867. PubMed ID: 28628040
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
Girer NG; Murray IA; Omiecinski CJ; Perdew GH
J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
[TBL] [Abstract][Full Text] [Related]
9. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
10. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
[TBL] [Abstract][Full Text] [Related]
11. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
Iizuka K
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
[TBL] [Abstract][Full Text] [Related]
12. ChREBP Reciprocally Regulates Liver and Plasma Triacylglycerol Levels in Different Manners.
Iizuka K; Takao K; Kato T; Horikawa Y; Takeda J
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30405056
[TBL] [Abstract][Full Text] [Related]
13. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice.
Fan Q; Nørgaard RC; Bindesbøll C; Lucas C; Dalen KT; Babaie E; Itkonen HM; Matthews J; Nebb HI; Grønning-Wang LM
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28661453
[TBL] [Abstract][Full Text] [Related]
14. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.
Dentin R; Benhamed F; Pégorier JP; Foufelle F; Viollet B; Vaulont S; Girard J; Postic C
J Clin Invest; 2005 Oct; 115(10):2843-54. PubMed ID: 16184193
[TBL] [Abstract][Full Text] [Related]
16. A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response.
Iroz A; Montagner A; Benhamed F; Levavasseur F; Polizzi A; Anthony E; Régnier M; Fouché E; Lukowicz C; Cauzac M; Tournier E; Do-Cruzeiro M; Daujat-Chavanieu M; Gerbal-Chalouin S; Fauveau V; Marmier S; Burnol AF; Guilmeau S; Lippi Y; Girard J; Wahli W; Dentin R; Guillou H; Postic C
Cell Rep; 2017 Oct; 21(2):403-416. PubMed ID: 29020627
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism.
Lee HJ; Cha JY
BMB Rep; 2018 Sep; 51(9):429-436. PubMed ID: 30158026
[TBL] [Abstract][Full Text] [Related]
18. Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBPα and ChREBPβ Expression.
Stamatikos AD; da Silva RP; Lewis JT; Douglas DN; Kneteman NM; Jacobs RL; Paton CM
Lipids; 2016 Jan; 51(1):95-104. PubMed ID: 26526060
[TBL] [Abstract][Full Text] [Related]
19. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
[TBL] [Abstract][Full Text] [Related]
20. Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.
Lundsgaard AM; Fritzen AM; Sjøberg KA; Myrmel LS; Madsen L; Wojtaszewski JFP; Richter EA; Kiens B
Mol Metab; 2017 Jan; 6(1):22-29. PubMed ID: 28123934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
